06 December 2024
06 December 2024
Veeva Europe president Chris Moore talks about the company’s new genAI-powered releases and its move from Salesforce to a proprietary CRM platform.
The implant is set to be available commercially in the US market by Q1 next year.
FieldForce is the first pulsed field ablation (PFA) system specifically designed for ventricular tachycardia ablation.
The MHRA is looking at five technologies in its AI Airlock pilot scheme, looking to inform its regulatory approach.
Lane Major, the company’s new CEO, takes over the helm from founder Jeffrey Johnson.
More than ten medical institutions have initiated purchase order processes for the RenovoCath device.
Data has the power to impact surgical outcomes, starting before patients step into the operating room.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
